WO2025163556 - METHODS FOR TREATING CANCER
National phase entry is expected:
Publication Number
WO/2025/163556
Publication Date
07.08.2025
International Application No.
PCT/IB2025/051032
International Filing Date
30.01.2025
Title **
[English]
METHODS FOR TREATING CANCER
[French]
MÉTHODES DE TRAITEMENT DU CANCER
Applicants **
NOVARTIS AG
Inventors
AIMONE, Paola Daniela
GUETTNER, Achim
MORAN, Stephen
MORSE, Sophie
Priority Data
63/627,853
01.02.2024
US
63/642,999
06.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4335 | |
| EPO | Filing, Examination, Granting | 60952 | |
| Japan | Filing, Examination, Granting | 4050 | |
| South Korea | Filing, Examination, Granting | 5872 | |
| USA | Filing, Examination, Granting | 17740 |
Total:
92,949
Contact Us
Abstract[English]
Provided herein are methods for the treatment of cancers including pancreatic cancer, lung cancer, or breast cancer comprising administering to a subject in need thereof a FAP- targeting radiotherapeutic agent either as a monotherapy or in combination with one or more chemotherapeutic agents.[French]
L'invention concerne des méthodes de traitement de cancers comprenant le cancer du pancréas, le cancer du poumon ou le cancer du sein, comprenant l'administration à un sujet qui en a besoin d'un agent de radiothérapie ciblant la FAP, soit sous la forme d'une monothérapie, soit en combinaison avec un ou plusieurs agents chimiothérapeutiques.